Trial · NCT04035668
Results by group169
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 169
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) Total Score at Week 24 | Remibrutinib 100 mg qd | -4.70 | Standard Error 0.78 | score on scale | |
| Change From Baseline in EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) Total Score at Week 24 | Remibrutinib 100 mg Bid | -3.70 | Standard Error 0.80 | score on scale | |
| Change From Baseline in EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) Total Score at Week 24 | Any Remibrutinib | -4.20 | Standard Error 0.56 | score on scale | |
| Change From Baseline in EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) Total Score at Week 24 | Placebo | -1.34 | Standard Error 0.74 | score on scale | |
| Change From Baseline in ESSDAI Total Score Over Time | Remibrutinib 100 mg qd | Week 2 | -1.68 | Standard Error 0.52 | score on scale |
| Change From Baseline in ESSDAI Total Score Over Time | Remibrutinib 100 mg Bid | Week 2 | -1.05 | Standard Error 0.52 | score on scale |
| Change From Baseline in ESSDAI Total Score Over Time | Any Remibrutinib | Week 2 | -1.37 | Standard Error 0.37 | score on scale |
| Change From Baseline in ESSDAI Total Score Over Time | Placebo | Week 2 | -0.37 | Standard Error 0.55 | score on scale |
| Change From Baseline in ESSDAI Total Score Over Time | Remibrutinib 100 mg qd | Week 4 | -2.57 | Standard Error 0.60 | score on scale |
| Change From Baseline in ESSDAI Total Score Over Time | Remibrutinib 100 mg Bid | Week 4 | -2.54 | Standard Error 0.62 | score on scale |
| Change From Baseline in ESSDAI Total Score Over Time | Any Remibrutinib | Week 4 | -2.55 | Standard Error 0.43 | score on scale |
| Change From Baseline in ESSDAI Total Score Over Time | Placebo | Week 4 | -0.79 | Standard Error 0.61 | score on scale |
| Change From Baseline in ESSDAI Total Score Over Time | Remibrutinib 100 mg qd | Week 8 | -2.74 | Standard Error 0.72 | score on scale |
| Change From Baseline in ESSDAI Total Score Over Time | Remibrutinib 100 mg Bid | Week 8 | -2.93 | Standard Error 0.71 | score on scale |
| Change From Baseline in ESSDAI Total Score Over Time | Any Remibrutinib | Week 8 | -2.83 | Standard Error 0.51 | score on scale |
| Change From Baseline in ESSDAI Total Score Over Time | Placebo | Week 8 | -2.36 | Standard Error 0.69 | score on scale |
| Change From Baseline in ESSDAI Total Score Over Time | Remibrutinib 100 mg qd | Week 12 | -3.66 | Standard Error 0.74 | score on scale |
| Change From Baseline in ESSDAI Total Score Over Time | Remibrutinib 100 mg Bid | Week 12 | -2.56 | Standard Error 0.75 | score on scale |
| Change From Baseline in ESSDAI Total Score Over Time | Any Remibrutinib | Week 12 | -3.11 | Standard Error 0.53 | score on scale |
| Change From Baseline in ESSDAI Total Score Over Time | Placebo | Week 12 | -1.92 | Standard Error 0.73 | score on scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04035668/results